2024 MAGNIMS–CMSC–NAIMS consensus recommendations on the use of MRI for the diagnosis of multiple sclerosis
National Institute of Neurological Disorders and Stroke · National Institutes of Health · +23 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
54
total citations
- FWCI
- 59.54
- Percentile
- 100%
- References
- 103
Citations per year
Authors
34Topics & keywords
Topics
Keywords
- Multiple sclerosis
- Magnetic resonance imaging
- Clinical Practice
- McDonald criteria
- Spinal cord
- Medical imaging
No related works found for this paper.
Funding
- UDU.S. Department of Defense
- BSBristol-Myers Squibb
- ELEli Lilly and Company
- PPfizer
- AAstraZeneca
- SSanofi
- CHCraig H. Neilsen Foundation
- BBiogen
- POPatient-Centered Outcomes Research Institute
- TPTeva Pharmaceutical Industries
- APAlexion Pharmaceuticals
- CCelgene
- FIFondazione Italiana Sclerosi Multipla
- CBCSL Behring
- ECEuropean Committee for Treatment and Research in Multiple Sclerosis
- WTWellcome Trust
- MRMyelin Repair Foundation
- TTTG Therapeutics
- RTRace to Erase MS
- ABAtara Biotherapeutics
- MMylan
- KPKiniksa Pharmaceuticals
- MSMultiple Sclerosis Society of Canada
- NINational Institute for Health and Care Research
- MSMultiple Sclerosis Society
- RTRosetrees TrustAwards: PGL21/10079, A1332
- NRNational Research Foundation
- ZZonMwAward: 09150172010056
- MDMinistero della Salute
- NNNovo Nordisk
- SShionogi
- MSMultiple Sclerosis International FederationAward: MD1003
- SMSchweizerische Multiple Sklerose Gesellschaft
- NNeuraxpharm
- IPIdorsia Pharmaceuticals
- MPMedDay PharmaceuticalsAward: NCT02220244
- ANAmsterdam Neuroscience
- ICInternational Collaboration on Repair Discoveries
- NINational Institutes of Health
- GGenentech
- SSamsung
- ESEMD Serono
- AAllergan
- SGSanofi Genzyme
- NSNatural Sciences and Engineering Research Council of Canada
- MRMedical Research Council
- NHNational Health and Medical Research Council
- IDInstituto de Salud Carlos IIIAwards: PI22/01589, PI19/00950, PI22/00750
- JPJanssen Pharmaceuticals
- EEurostars